acyclovir

Generic: acyclovir

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir
Generic Name acyclovir
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

acyclovir 400 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-3250
Product ID 50090-3250_0c61c8ca-1f35-4ffa-b0a1-888b08f47f5f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204314
Listing Expiration 2026-12-31
Marketing Start 2014-09-10

Pharmacologic Class

Established (EPC)
herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc]
Mechanism of Action
dna polymerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500903250
Hyphenated Format 50090-3250

Supplemental Identifiers

RxCUI
197311
UNII
X4HES1O11F
NUI
N0000020060 N0000180187 N0000180188 N0000175468 N0000175459

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir (source: ndc)
Generic Name acyclovir (source: ndc)
Application Number ANDA204314 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
source: ndc
Packaging
  • 2 TABLET in 1 BOTTLE (50090-3250-0)
  • 25 TABLET in 1 BOTTLE (50090-3250-2)
  • 50 TABLET in 1 BOTTLE (50090-3250-3)
  • 15 TABLET in 1 BOTTLE (50090-3250-4)
  • 30 TABLET in 1 BOTTLE (50090-3250-5)
  • 60 TABLET in 1 BOTTLE (50090-3250-6)
  • 45 TABLET in 1 BOTTLE (50090-3250-9)
source: ndc

Packages (7)

50090-3250-0 2 TABLET in 1 BOTTLE (50090-3250-0) 50090-3250-2 25 TABLET in 1 BOTTLE (50090-3250-2) 50090-3250-3 50 TABLET in 1 BOTTLE (50090-3250-3) 50090-3250-4 15 TABLET in 1 BOTTLE (50090-3250-4) 50090-3250-5 30 TABLET in 1 BOTTLE (50090-3250-5) 50090-3250-6 60 TABLET in 1 BOTTLE (50090-3250-6) 50090-3250-9 45 TABLET in 1 BOTTLE (50090-3250-9)

Ingredients (1)

acyclovir (400 mg/1)

Linked Drug Pages (1)

acyclovir ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0c61c8ca-1f35-4ffa-b0a1-888b08f47f5f", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["c40a57b9-4cf1-4a69-abf3-eb99a7fcda00"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "2 TABLET in 1 BOTTLE (50090-3250-0)", "package_ndc": "50090-3250-0", "marketing_start_date": "20181015"}, {"sample": false, "description": "25 TABLET in 1 BOTTLE (50090-3250-2)", "package_ndc": "50090-3250-2", "marketing_start_date": "20171108"}, {"sample": false, "description": "50 TABLET in 1 BOTTLE (50090-3250-3)", "package_ndc": "50090-3250-3", "marketing_start_date": "20171108"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (50090-3250-4)", "package_ndc": "50090-3250-4", "marketing_start_date": "20171108"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-3250-5)", "package_ndc": "50090-3250-5", "marketing_start_date": "20171108"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (50090-3250-6)", "package_ndc": "50090-3250-6", "marketing_start_date": "20171108"}, {"sample": false, "description": "45 TABLET in 1 BOTTLE (50090-3250-9)", "package_ndc": "50090-3250-9", "marketing_start_date": "20171108"}], "brand_name": "acyclovir", "product_id": "50090-3250_0c61c8ca-1f35-4ffa-b0a1-888b08f47f5f", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "50090-3250", "generic_name": "acyclovir", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA204314", "marketing_category": "ANDA", "marketing_start_date": "20140910", "listing_expiration_date": "20261231"}